The primary outcome was device-pocket hematoma that necessitated prolonged hospitalization, interruption of anticoagulation, or further surgery. ... causes the bleeding to appear only postoperatively when full-dose anticoagulation is resumed.
I n his talk “Atrial Fibrillation: Risk Stratification, Anticoagulation, Future Development” at Hospital Medicine 2015, Zayd A. ... Dr. Eldadah summarized recommendations for thrombosis control. For patients with a mechanical heart valve, he said,
The patient has symptomatic venous thromboembolism and would likely benefit from immediate anticoagulation. ... 9. /L]) associated with pulmonary emboli is not a contraindication to anticoagulant therapy.
An alternative to plasma (Prothrombin Complex Concentrate, Human; brand name, Kcentra) was approved by the FDA last week for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with ... Like plasma, Kcentra is used in conjunction
Switching to aspirin or clopidogrel does not provide the same protective benefit, and it is not appropriate to discontinue all anticoagulation. ... Following atrial fibrillation ablation, anticoagulation should continue for 2 to 3 months; thereafter,
Researchers used the Veterans Affairs Study to Improve Anticoagulation database to identify 1, 763 patients with liver disease who were receiving oral anticoagulation with warfarin from Oct. ... The authors noted that most of the study patients were men
Researchers wrote that because many distal thrombi appear to resolve without anticoagulants, detection and treatment of distal DVT may be unnecessary. ... However, current clinical practice guidelines recommend 3 months of anticoagulation for distal DVT.
methods of stroke prevention, adjusted-dose oral vitamin K antagonist (VKA) therapy, and management of bleeding on oral anticoagulation, among other topics. ... When oral anticoagulation is recommended or suggested, the guidelines suggest using a novel
Apixaban linked to lower risk of serious bleeding compared to warfarin in patients with or without afib
A recent comparison of anticoagulants in a real-world population found apixaban to be the safest drug, with reduced risks of major, intracranial, and gastrointestinal bleeding compared to warfarin. ... Using data from two U.K. primary care databases,
The findings in patients with intracerebral hemorrhage suggest that non–vitamin K antagonist oral anticoagulants may be better than warfarin for patients requiring an anticoagulant with or without concomitant antiplatelet therapy, ... To the authors'